Keystone Symposia

Keystone Resort Floorplan

This meeting took place in 2022


Here are the related meetings in 2024:
Neurodegenerative Diseases (Z3)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Neurodegeneration: The Biological Pathways Driving the Future of Therapeutic Development (Z2)


Organizer(s) Dimitri Krainc and Alfred Sandrock
June 5—9, 2022
Keystone Resort • Keystone, CO USA
Abstract Deadline: Mar 1, 2022
Scholarship Deadline: Feb 22, 2022
Discounted Registration Deadline: Apr 5, 2022

Sponsored by Biogen, Ionis Pharmaceuticals, Inc., Lilly USA, LLC, Merck & Co., Inc. and PhenoVista Biosciences


Summary of Meeting:
Neurodegenerative diseases remain one of the main concerns for aging populations across the world. Elucidating the molecular mechanisms underlying these diseases thus remains a priority for developing effective therapeutics to combat them. Recent genetic studies linked to these diseases have pointed to functional defects in several key cellular organelles and pathways that appear to drive neurodegeneration, including endolysosomal, mitochondrial and synaptic dysfunctions. However, there is still much to be learned regarding the precise roles of these pathways in disease progression, their contribution to neuronal vulnerability, and how to effectively target these pathways in patients. Important mechanistic themes in neurodegenerative disease include the genetics of neuro-immune interactions, the involvement of synaptic molecular events, the role of endolysosomal, autophagic and mitochondrial dysfunction, the potential contribution of dynamic inter-organelle contact sites in neurons, and translational considerations including the use of biomarkers and gene therapy. The goal of this conference is to bring together fundamental basic scientists who are experts in these areas of cell biology, together with clinicians and medical researchers, and scientists investigating therapeutic strategies for neurodegeneration. By combining these different fields of expertise, this conference will stimulate cross-fertilization, in-depth interactions and insightful discussions on disease pathogenesis and strategies for advancing drug development for neurodegenerative disorders. Finally, this conference is being paired with a conference on Neuro-Immune Interactions in the Central Nervous System. This combination will be beneficial in that it will emphasize the crossover between neurodegeneration and neuroimmunology. As neuroimmunology is a recently reinvigorated field, this meeting will provide a critical opportunity to foster cross-disciplinary thinking.

View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, June 5 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, June 9 with a closing plenary session from 17:00 to 19:00, followed by a social hour. We recommend return travel on Friday, June 10 in order to fully experience the meeting.

SUNDAY, JUNE 5

16:00—20:00
Arrival and Registration

Longs Peak Foyer
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Longs Peak Foyer

MONDAY, JUNE 6

07:00—08:00
Breakfast

Colorado Rockies Ballroom
08:00—09:30
Welcome and Keynote Session (Joint) (8:00 am Start)

Grays/Longs Peaks
* Marco Colonna, Washington University School of Medicine, USA
Session Chair

* Dimitri Krainc, Northwestern University, USA
Session Chair

Thomas C. Südhof, Stanford School of Medicine, USA
Synapse Biology in Alzheimer's Disease

David M. Holtzman, Washington University, USA
Innate Immunity, ApoE, and Neurodegeneration

Coffee Break

09:50—11:15
Genetics of Neuro-Immune Interactions (Joint) (9:50 am Start)

Grays/Longs Peaks
David Gate, Northwestern University, USA
Cerebrospinal Fluid Immunity in Aging and Neurodegenerative Disease

* Alison Goate, Icahn School of Medicine at Mount Sinai, USA
Alzheimer's Disease Susceptibility Alleles Implicate Efferocytosis in Microglia

Le Zhang, Yale University, USA
Short Talk: Neuro-immune Interactions in the Parkinson's Disease

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

Colorado Rockies Ballroom
13:00—22:00
Poster Viewing

Colorado Rockies Ballroom
14:30—16:30
Workshop 1: Neuro-Immune Interactions in Neurological Diseases (2:30 pm Start)

Longs Peak
Zahara M. Keulen, UC Irvine, USA
Neuronal Tau Pathology Alters Human Microglial Morphology, Transcriptome, and Function

Denise Jurczyszak, Icahn School of Medicine at Mount Sinai, USA
Investigation of Neuroinflammation in Down Syndrome

* Gregory Williams, La Jolla Institute for Immunology, USA
PINK1 Identified as a Target of Autoantigenic T Cells Responses in Patients with PD

Esra Yalcin, Boston Children's Hospital, USA
Viral Expression of Anti hC4 Nanobody (hC4Nb8) Rescues Schizophrenia like Phenotypes in hC4A Mice

Sean Ryan, Sanofi, USA
Microglia Ferroptosis is Prevalent in Neurodegenerative Disease and Regulated by SEC24B

Xiaoying Chen, Washington University School of Medicine, USA
Microglia-mediated T cell Infiltration in Tauopathy

* Maria Serena Paladini, University of California San Francisco, USA
Fate Mapping Of Peripherally Derived Macrophages After Traumatic Brain Injury

Gabrielle Childers, University of Alabama at Birmingham, USA
Exploring the Role of B Cells in a Mouse Model of Multiple System Atrophy

16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:15
Synaptic Mechanisms and Molecular Events (5:00 pm Start)

Grays Peak
* Pietro V. De Camilli, Yale University School of Medicine, USA
The VPS13 Family of Lipid Transport Proteins and Neurodegeneration

Morgan H. Sheng, Broad Institute of MIT and Harvard, USA
Mechanisms of Synapse Loss in Neurodegenerative Disease

Maria Grazia Spillantini, University of Cambridge, UK
Synaptic Dysfunction in Parkinson's Disease

Volker Haucke, Leibniz Forschungsinstitut für Molekulare Pharmakologie, Germany
The Alzheimer´s Disease Risk Factor CALM Controls Synaptic Plasticity by a GluA1-specific Endocytic Mechanism

Emma L. Clayton, King's College London, UK
Short Talk: A Novel Synaptopathy- Defective Synaptic Vesicle Protein Trafficking in the Mutant CHMP2B Mouse Model of Frontotemporal dementia

17:00—19:00
Understanding Immune Receptors in the CNS (5:00 pm Start)

Longs Peak
Greg E. Lemke, The Salk Institute for Biological Studies, USA
TAM Receptor Regulation of Neurodegenerative Disease

* Marco Colonna, Washington University School of Medicine, USA
ITAM Signaling in Neurodegeneration

Hugo Peluffo, Institut Pasteur de Montevideo/UDELAR/Universitat de Barcelona, Uruguay
Short Talk: CD300f Immune Receptor Contributes To Healthy Aging By Regulating Inflammaging, Metabolism And Cognitive Decline

Jose Ledo, Rockefeller University / Boston Children's Hospital - Harvard Medical School, USA
Short Talk: Microglia Modulate Neuronal Activity and Learning and Memory via Presenilin 1-Trem2

Nelli Blank, University Bonn, LIMES Institute, Germany
Short Talk: Impact of Aging and Cxcr4-deficiency on the Immune Response of Microglia and Monocytes upon Experimental Stroke

James Hamilton, Eli Lilly and Company, USA
Short Talk: TREM2 Limits Age-related Neurodegeneration and Modifies ß-amyloid Environment to Restrict Tau Seeding and Spreading

19:15—20:15
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
19:30—22:00
Poster Session 1

Colorado Rockies Ballroom

TUESDAY, JUNE 7

07:00—08:00
Breakfast

Colorado Rockies Ballroom
07:30—08:00
Poster Setup

Colorado Rockies Ballroom
08:00—19:00
Poster Viewing

Colorado Rockies Ballroom
08:00—11:00
Autophagy and Disease (8:00 am Start)

Grays Peak
* Ivan Dikic, Goethe University Medical School, Germany
ER-phagy: From Molecular Principles to Pathogenesis of Neuropathies

Xinnan Wang, Stanford University School of Medicine, USA
Converging Cellular Pathways in Parkinson's Disease

Coffee Break

Elizabeth A. Eckman, Biomedical Research Institute of New Jersey, USA
Regulation of Intravesicular Aβ by ECE-1: Implications for Aβ Aggregation and Secretion

Rebecca Wallings, University of Florida, USA
Short Talk: Bi-phasic, Age-dependent Alterations in Lysosomal Function and Immune Responses in R1441C-Lrrk2 Macrophages

Kang-Chieh Huang, Indiana University Purdue University Indianapolis, USA
Short Talk: Autophagy Impairment Contributes to Neurodegeneration via Repression of mTORC1 Signaling in a Human Pluripotent Stem Cell Model of Glaucoma-Associated Neurodegeneration

Dan Dou, University of Pennsylvania, USA
Short Talk: LRRK2 Hyperactivity Induced by Parkinson's Disease-associated Mutations Disrupts Autophagic Vesicle Transport along the Axon

Celia McKee, Washington University in St. Louis, USA
Short Talk: The Astrocyte Circadian Clock Regulates Autophagy and Endolysosome Function

08:00—11:00
Microglia, Other Glial Cells and Macrophages in Neurodegenerative Diseases (8:00 am Start)

Longs Peak
* Michael T. Heneka, University of Luxembourg, Luxembourg
Microglia Support Neurons through Tunneling Nanotubes

Rosa C. Paolicelli, University of Lausanne, Switzerland
Metabolic Control of Microglial Function

Coffee Break

Marco Prinz, University of Freiburg, Germany
Origin and Fate of Brain Macrophages

Dorothy Schafer, University of Massachusetts Chan Medical School, USA
Microglial-Astrocyte Wnt Signaling: A Key Regulator of Neural Circuit Remodeling

Mickaël Audrain, AC Immune, Switzerland
Short Talk: Microglia and the NLRP3 Inflammasome Pathway Contribute to Tau-mediated Pathology in vivo

Lindsay De Biase, UCLA, USA
Short Talk: Microglia Drive Pockets of Neuroinflammation in Middle Age

11:00—12:30
Lunch

Colorado Rockies Ballroom
12:00—14:30
Poster Session 2

Colorado Rockies Ballroom
14:30—16:30
Workshop: Cellular Pathways Driving Disease (2:30 pm Start)

Grays Peak
* Dimitri Krainc, Northwestern University, USA
Session Chair

Kelsey Babcock, Brown University, USA
Linking Defects in the Quiescent Neural Stem Cell Pool to Impaired Adult Hippocampal Neurogenesis in Alzheimer's Disease

Tianmin Fu, Ohio State University, USA
Roles of TMEM175 in Lysosomal pH Homeostasis and Parkinson's Diseases

Kelsey Krus, Washington University in St. Louis, USA
Loss of Stathmin-2, a Hallmark of TDP-43-Associated ALS, Causes Motor Neuropathy

Anthony Flamier, Whitehead Institute, USA
Impact Of DNA Methylation Changes on Alzheimer's Disease

Brian P. Hafler, Yale University, USA
Topological Analysis of Single-cell Hierarchy Reveals Inflammatory Glial Landscape of Macular Degeneration

Drew A. Gillett, University of Florida, USA
BMP Modification in a Progranulin (PGRN) Deficient Cell Line

Patrick W. Sheehan, Washington University in St. Louis, USA
Glia Reprogram Circadian Gene Transcription During Aging and Disease

Andy P. Tsai, Indiana University School of Medicine, USA
Impact of PLCG2 Variants on Microglial Biology and Disease Pathogenesis in Alzheimer's Disease

14:30—16:30
Workshop 2: IPSC and Organoids for the Study of Neurodegeneration (2:30 pm Start)

Longs Peak
* Alice Buonfiglioli, Icahn School of Medicine at Mount Sinai, USA
A New Cerebral Organoid Culture Model to Study the Effects of Novel Drugs Targeting Microglia

Jean Paul Chadarevian, UC Irvine, USA
Harnessing iPSC-derived Microglia to Delivery Therapeutics in the Brain

Olivia Teter, UCSF, USA
Uncovering Regulators of Synaptic Pruning by CRISPRi in an iPSC-derived Microglia-neuron Co-culture System

Marvin Reich, German Center for Neurodegenerative Diseases, Germany
Neuron-microglia Crosstalk in a Human iPSC-based FTD Model

* Amanda McQuade, Institute for Neurodegenerative Diseases, UCSF, USA
Dampening Purinergic Signaling in TREM2-knockout iPSC-microglia Rescues Chemotactic Deficit

Caleb C. Stokes, University of Washington, USA
Single Cell RNA Sequencing of Zika Infection in Human Neural Tissues Reveals an Astrocyte-Driven Innate Immune Response Governed by Interferon Beta

Sandra Siegert, Institute of Science and Technology Austria, Austria
How MorphOMICs Challenges Current Morphological Analysis Strategies and Links Shape to Function.

Juan J. Ramirez, Duke University, USA
An Astrocyte to Microglia Signaling Pathway that Controls the Balance Between Synapse Formation and Synapse Elimination

16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:00
Endolysosomal Dysfunction in Neurodegeneration (5:00 pm Start)

Grays Peak
Dimitri Krainc, Northwestern University, USA
Convergence of Mitochondrial and Lysosomal Dysfunction

* Ralph A. Nixon, New York University, Langone Medical Center, USA
Defective Endolysosomal Function in Alzheimer's Disease

Roberto Zoncu, University of California, Berkeley, USA
mTOR and Lysosomes in Nutrient Sensing and Growth Control

Hankum Park, Seoul National University, South Korea
Short Talk: Spatial Snapshots of Amyloid Precursor Protein Intramembrane Processing via Early Endosome Proteomics

Sofia Massaro Tieze, Yale University, USA
Short Talk: Molecular Characterization of Lipofuscin Pathology in Neuronal Ceroid Lipofuscinosis

17:00—19:00
The Role of Brain Immune System in Shaping the CNS Connectivity (5:00 pm Start)

Longs Peak
Jun R. Huh, Harvard Medical School, USA
Impact of Gut Bacteria in Neurodevelopmental Abnormalities

* Katerina Akassoglou, Gladstone Institutes, University of California, San Francisco, USA
Microglia Regulation of Brain Network Hyperexcitability

Anne Schaefer, Icahn School of Medicine at Mount Sinai, MPI Ageing, USA
Control of Neuronal Activity by Microglia

Jerika J. Barron, University of California, San Francisco, USA
Short Talk: Type 2 Innate Lymphocytes Promote Inhibitory Synapse Development and Social Memory

Mario R. Capecchi, University of Utah, USA
Short Talk: Defective Hoxb8 Microglia are Causative for both Chronic Anxiety and OCSD-like Behavior in Mice

19:00—21:00
On Own for Dinner


WEDNESDAY, JUNE 8

07:00—08:00
Breakfast

Colorado Rockies Ballroom
08:00—11:00
Mitochondrial Defects in Neurodegeneration (8:00 am Start)

Grays Peak
* Dalton James Surmeier, Northwestern University, USA
Bioenergetic Determinants of Selective Neuronal Vulnerability in Parkinson's Disease

Richard J. Youle, NINDS, National Institutes of Health, USA
Pharmacologic Strategies to Target Mitochondria and Protein Aggregates Toward Autophagy

Coffee Break

Yvette C. Wong, Northwestern University, USA
Mitochondria-Lysosome Contact Sites: Roles and Regulation in Homeostasis and Neurodegenerative Diseases

Anna Barron, Nanyang Technological University, Singapore
Remote Presentation: Short Talk: Regulation of Microglial Immunometabolic Programming in Alzheimer's Disease

Isaac Pieter Heremans, UCLouvain, Belgium
Short Talk: Parkinson's Disease Protein PARK7 Prevents Metabolite and Protein Damage Caused by a Glycolytic Metabolite

08:00—11:00
Application of Next Generation Technologies to Profile Neuro Immune Interactions (8:00 am Start)

Longs Peak
* Marco Colonna, Washington University School of Medicine, USA
Session Chair

Soyon Hong, University College London, UK
Talk Title to be Announced

Matheus B. Victor, Massachusetts Institute of Technology, USA
Talk Title to be Announced

Coffee Break

Christopher K. Glass, University of California, San Diego, USA
Decoding Microglia Enhancers in Health and Disease

Félix Distéfano-Gagné, Laval University, Canada
Short Talk: Dynamic Regulation of the Microglial Transcriptional Landscape During Neuroinflammatory Response

Inbal Benhar, Weizmann Institute of Science, Israel
Short Talk: Single-Cell Profiling of Non-Neuronal Retinal Cells Reveals Dynamic Multicellular Responses to Central Nervous System Injury

Ido Amit, Weizmann Institute, Israel
Remote Presentation: The Power of ONE: Immunology in the Age of Single Cell Genomics

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

Colorado Rockies Ballroom
13:00—22:00
Poster Viewing

Colorado Rockies Ballroom
14:30—16:30
Career Roundtable (Joint) (2:30 pm Start)

Castle Peaks 1-2
Malu G. Tansey, University of Florida, USA

Anabella Villalobos, Biogen, USA

Carole Ho, Denali Therapeutics Inc., USA

Xinnan Wang, Stanford University School of Medicine, USA

Yvette C. Wong, Northwestern University, USA

16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—19:00
Neuronal Pathways in Disease (5:00 pm Start)

Grays Peak
* Virginia M. Y. Lee, University of Pennsylvania School of Medicine, USA
Alpha-Synuclein from Patient Lewy Bodies Exhibits Distinct Pathological Activity that can be Propagated in vitro

Martin Kampmann, University of California, San Francisco, USA
CRISPR-based Functional Genomics for Neurological Disease

Juliana Laverde Paz, University of Miami, USA
CRISPR/Cas9-Mediated Excision of ALS/FTD-Causing Hexanucleotide Repeat Expansion in C9ORF72 Rescues Major Disease Mechanisms in vivo and in vitro

Jennifer Rauch, University of Massachusetts Amherst, USA
Short Talk: Deciphering the Molecular Features Underlying LRP1-Mediated Tau Spread

17:00—19:00
Brain Immune System in Neuroinflammation (5:00 pm Start)

Longs Peak
Menna Clatworthy, University of Cambridge, UK
Plasma Cells in the Meninges

* Malu G. Tansey, University of Florida, USA
Immune Function and Inflammation in Parkinson's Disease

Francisco J. Quintana, Harvard Medical School and the Broad Institute of MIT and Harvard, USA
Impact of Aryl Hydrocarbon Receptor in Multiple Sclerosis

Stephanie Ann Michalski, Saint Louis University School of Medicine, USA
Short Talk: T-lymphocyte and Microglial Paracrine Signaling Promotes Epilepsy-Associated Neuroinflammation

Xiao Le Michelle Zuo, University of Toronto, Canada
Short Talk: Ageing Promotes Grey Matter Demyelination and Neurodegeneration that is Associated with Meningeal Neutrophil Accumulation in an Animal Model of Multiple Sclerosis

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom
19:30—22:00
Poster Session 3

Colorado Rockies Ballroom

THURSDAY, JUNE 9

07:00—08:00
Breakfast

Colorado Rockies Ballroom
08:00—11:00
Translational Considerations in Neurodegenerative Research (8:00 am Start)

Grays Peak
* Alfred Sandrock, Voyager Therapeutics, USA
Challenges of Going from Bench to Bedside in Neurology

Grigorios G. Papageorgiou, University of New Mexico, USA
A Downregulated Circular RNA in Alzheimer's Disease can Inhibit the Expression of Disease-associated Long APP and MAPT mRNA Isoforms in the Frontal Cortex

Coffee Break

Carole Ho, Denali Therapeutics Inc., USA
Early Clinical Development: Achieving Proof of Biology and Dose Selection Prior to Registration Enabling Clinical Studies

Yemima Riani Butler, University of Michigan, USA
Short Talk: Fibril-specific Nanobody Prevents Prion-like α-Synuclein Spreading

Vivian Ko, UCSD, USA
Short Talk: CK1ε-dependent TDP-43 Phosphorylation in ALS

08:00—11:00
Blood Brain Barrier (BBB), Glymphatics and Lymphatics (8:00 am Start)

Longs Peak
Jonathan Kipnis, Washington University School of Medicine, USA
Meningeal Sinuses and Lymphatics in the Epicenter of CNS Immune Surveillance

* Zsuzsanna Fabry, University of Wisconsin, USA
How Does the Meningeal Lymphatics Respond to Neuroinflammation in Autoimmunity, Infection and Trauma?

Coffee Break

Simone Di Giovanni, Imperial College London, UK
Neuroimmune Interactions Control the Regenerative Ability of the Nervous System Across the Lifespan

Jorge I. Alvarez, University of Pennsylvania, USA
Short Talk: Heterogeneity in the CNS Endothelium Identifies the Blood Meningeal Barrier as an Orchestrator of Neuroinflammation

Matthew N. Poy, Johns Hopkins All Children's Hospital, USA
Short Talk: Glutamatergic Argonaute2 Regulates Formation of the Neurovascular Unit

11:00—12:00
Panel: Challenges Associated with Transforming Novel Human Genetic Insights into Disease-Modifying Therapies (11:00 am Start)

Longs Peak
* Shilpa Sambashivan, Nura Bio, USA
Session Chair

Arnon Rosenthal, Alector, USA

Carole Ho, Denali Therapeutics Inc., USA

Matthew Kennedy, Merck Research Labs, USA

Marco Colonna, Washington University School of Medicine, USA

Christian Mirescu, Vigil Neuroscience, USA

11:00—17:00
On Own for Lunch

14:30—16:30
Workshop 3: Immunotherapy of Neurodegeneration (2:30 pm Start)

Longs Peak
* Gerard Crowley, University College London, UK
Chemogenetic Activation of Perforant Pathway Induces Microglial Complement Signalling and Synapse Loss

John F. Tuddenham, Columbia University, USA
Towards Manipulation of Microglial Subsets in Humans: A Toolkit for Modulating Microglia in a Targeted Fashion

Stephanie Bissel, Indiana University, USA
Reduced PLCG2 Expression Alters Microglial Responses and Exacerbates Disease Pathology in a Murine Model of Alzheimer's Disease

Zena K. Chatila, Columbia University, USA
Interaction of Alzheimer's Disease Risk Variants and Amyloid on Innate Immune Function

Hyuncheol Jung, Korea Advanced Institute of Science and Technology, South Korea
Anti-inflammatory Clearance of Amyloid Beta by a Chimeric Gas6 Fusion Protein

* Lindsay N. Hayes, Johns Hopkins University, USA
Prenatal Immune Stress Induces Blunting of Microglia Reactivity that Impairs Striatal Connectivity

Afsana Sabrin, Columbia University, USA
Microglial and Astrocyte Signatures in CSF Proteome: Developing Markers for Glial Cell Subtypes in CSF

Christina Seitz, Karolinska Institutet, Sweden
T Cell Responses at Diagnosis of Amyotrophic Lateral Sclerosis Predict Disease Progression

16:30—17:00
Coffee Available

Longs Peak Foyer
17:00—18:45
Future Directions for Therapeutics (5:00 pm Start)

Grays Peak
* Anabella Villalobos, Biogen, USA
Therapeutic Modalities for Neuroscience Diseases

C. Frank Bennett, Ionis Pharmaceuticals, Inc., USA
Antisense Oligonucleotides for Neurological Diseases: What Are We Learning From the Clinic?

Jana Mitchell, Insitro, USA
Machine Learning for Unraveling the Complex Biology of CNS Disease

Juan A. Varela, University of St Andrews, UK
Short Talk: Clearance of Extracellular Amyloid-beta Aggregates from the Brain at the Nano-scale

17:00—18:45
Aging, Metabolism and Neurodegeneration (5:00 pm Start)

Longs Peak
Tony Wyss-Coray, Stanford University School of Medicine, USA
Remote Presentation: Systemic Regulation of Brain Aging

* Katrin Andreasson, Stanford University, USA
Myeloid Cell Metabolism in Aging

Douglas R. Green, St. Jude Children's Research Hospital, USA
Perchance to Dream: Sleep and Inflammation

Tal Iram, Stanford University, USA
Short Talk: Young CSF Restores Oligodendrogenesis and Memory in Aged Mice via Fgf17

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers) (6:45 pm Start)

Grays Peak
18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)

Longs Peak
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Colorado Rockies Ballroom

FRIDAY, JUNE 10

08:00—08:00
Departure


*Session Chair †Invited, not yet responded.



Keystone Symposia thanks our Sponsors(s) for generously supporting this meeting:

Biogen Ionis Pharmaceuticals, Inc.
Lilly USA, LLC Merck & Co., Inc.
PhenoVista Biosciences
 

We gratefully acknowledge additional support from these exhibitors at this conference:

10x Genomics
Please stop by to meet these exhibitors during the conference.


We gratefully acknowledge additional support for this conference from:

eLife Science Immunology / AAAS
Montana Molecular
 

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



Biogen


Denali Therapeutics Inc.


Ionis Pharmaceuticals, Inc.


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: John Monson, Director of Corporate Relations, Email: johnm@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Josh May, Director, Technology and Digital Media, Email: joshuam@keystonesymposia.org,
Phone:+1 970-262-1179